FDA Inspection 1112164 — Rohto-Mentholatum (Vietnam) Co., Ltd.
The FDA completed an inspection of Rohto-Mentholatum (Vietnam) Co., Ltd. on Nov 1, 2019 in Ho Chi Minh. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 1, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ho Chi Minh (Vietnam)